ストックスクリーナーアプリを入手
2.26
2.03%
0.04
前日終値:
$2.22
開ける：
$2.26
24時間の取引高:
3.37M
Relative Volume:
0.23
時価総額：
$817.79M
収益：
$241.53M
当期純損益:
$-389.92M
株価収益率:
-1.8374
EPS:
-1.23
ネットキャッシュフロー:
$-323.54M
1週間 パフォーマンス:
-6.40%
1か月 パフォーマンス:
-9.40%
6か月 パフォーマンス:
-36.55%
1年 パフォーマンス:
-77.73%
1日の値動き範囲:
$2.21
$2.34
1週間の範囲:
$2.19
$2.43
52週間の値動き範囲:
$1.6385
$12.51
Iovance Biotherapeutics Inc Stock (IOVA) Company Profile
名前
Iovance Biotherapeutics Inc
セクター
電話
(650) 260-7120
住所
825 INDUSTRIAL ROAD, SAN CARLOS
IOVA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IOVA
Iovance Biotherapeutics Inc
|
2.26 | 803.32M | 241.53M | -389.92M | -323.54M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
386.74 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
587.54 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.44 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
726.93 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
338.36 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Iovance Biotherapeutics Inc Stock (IOVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-15 | ダウングレード | Goldman | Neutral → Sell |
| 2025-05-16 | ダウングレード | UBS | Buy → Neutral |
| 2025-05-12 | ダウングレード | Truist | Buy → Hold |
| 2025-05-09 | ダウングレード | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-07-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-11-20 | 開始されました | Goldman | Buy |
| 2023-09-18 | 繰り返されました | Barclays | Overweight |
| 2023-05-30 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-03-27 | 再開されました | Wells Fargo | Equal Weight |
| 2023-01-27 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-12-09 | ダウングレード | Goldman | Buy → Neutral |
| 2022-10-31 | 開始されました | Guggenheim | Neutral |
| 2022-08-18 | 再開されました | Wells Fargo | Equal Weight |
| 2022-01-28 | アップグレード | Stifel | Hold → Buy |
| 2021-12-07 | 再開されました | Cowen | Outperform |
| 2021-06-10 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2021-05-20 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-05-19 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2021-05-19 | ダウングレード | Stifel | Buy → Hold |
| 2021-05-03 | 開始されました | Truist | Buy |
| 2021-04-16 | 開始されました | Goldman | Buy |
| 2021-03-08 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-12-15 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-10-06 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-04-22 | 開始されました | Mizuho | Buy |
| 2020-03-04 | 開始されました | Barclays | Overweight |
| 2020-02-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-02-26 | 繰り返されました | Oppenheimer | Outperform |
| 2019-12-18 | 開始されました | JMP Securities | Mkt Outperform |
| 2019-10-01 | 開始されました | Stifel | Buy |
| 2019-04-29 | 開始されました | Piper Jaffray | Overweight |
| 2019-02-28 | 繰り返されました | Chardan Capital Markets | Buy |
| 2019-02-07 | 開始されました | Robert W. Baird | Outperform |
| 2018-12-31 | 再開されました | B. Riley FBR | Buy |
| 2018-07-06 | 繰り返されました | Chardan Capital Markets | Buy |
| 2018-04-10 | アップグレード | B. Riley FBR, Inc. | Neutral → Buy |
| 2018-03-13 | 繰り返されました | B. Riley FBR, Inc. | Neutral |
| 2018-02-23 | ダウングレード | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-01-25 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-11-01 | 繰り返されました | B. Riley FBR, Inc. | Buy |
すべてを表示
Iovance Biotherapeutics Inc (IOVA) 最新ニュース
Advancing Cancer Research Brings New Hope for Patients Worldwide - Benzinga
Bearish Setup: Can Iovance Biotherapeutics Inc stock double in the next yearJuly 2025 Trade Ideas & Scalable Portfolio Growth Ideas - خودرو بانک
Sectors Review: Is Iovance Biotherapeutics Inc attractive at current valuationFed Meeting & Free Long-Term Investment Growth Plans - خودرو بانک
Aug Chart Watch: Is Iovance Biotherapeutics Inc being accumulated by smart moneyGap Up & Weekly Top Performers Watchlists - خودرو بانک
Iovance Biotherapeutics Updates Corporate Presentation - MSN
Aug Breakouts: Is Iovance Biotherapeutics Inc forming a bullish divergenceQuarterly Trade Report & Consistent Profit Trading Strategies - خودرو بانک
Fibrogen leads drug developer stock gains on China sale, FDA update - BioWorld MedTech
Is Iovance Biotherapeutics Inc showing insider buyingTrade Entry Report & Expert-Curated Trade Recommendations - خودرو بانک
Nasdaq Moves: How does Iovance Biotherapeutics Inc score in quality rankingsJuly 2025 Highlights & Entry and Exit Point Strategies - خودرو بانک
Published on: 2025-09-16 06:42:56 - خودرو بانک
Entry Recap: Should I buy Iovance Biotherapeutics Inc. stock now2025 Technical Patterns & Weekly High Conviction Ideas - خودرو بانک
Market Overview: Can Iovance Biotherapeutics Inc. maintain sales growth2025 Retail Activity & Stepwise Swing Trade Plans - خودرو بانک
Stock Analysis: Why is Iovance Biotherapeutics Inc stock going upJuly 2025 Rallies & Capital Protection Trading Alerts - خودرو بانک
Bull Run: Will Iovance Biotherapeutics Inc benefit from AI trends2025 Geopolitical Influence & Entry and Exit Point Strategies - خودرو بانک
RSI Check: What are Iovance Biotherapeutics Inc.’s earnings expectationsEarnings Beat & Real-Time Volume Analysis - خودرو بانک
Iovance falls after missing Q2 expectation - MSN
Jacobs Levy Equity Management Inc. Invests $4.19 Million in Iovance Biotherapeutics, Inc. $IOVA - MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Average Rating of "Hold" by Brokerages - MarketBeat
Iovance Biotherapeutics, Inc. $IOVA Position Cut by American Century Companies Inc. - MarketBeat
Why Iovance Biotherapeutics Stock Plummeted Today - MSN
Invenomic Capital Management LP Purchases Shares of 5,489,799 Iovance Biotherapeutics, Inc. $IOVA - MarketBeat
Iovance Biotherapeutics at H.C. Wainwright Conference: Strategic Growth and Efficiency - Investing.com Canada
Growth Review: Will Iovance Biotherapeutics Inc. stock go up in YEARRisk Management & Stepwise Swing Trade Plans - Lancaster City Council
Is Iovance Biotherapeutics Inc. Forming a Consolidation BaseMarket Activity Report & Weekly Setup with High ROI Potential - beatles.ru
Iovance Biotherapeutics, Inc. $IOVA Shares Sold by Hsbc Holdings PLC - Defense World
H.C. Wainwright Keeps Buy Rating on Iovance (IOVA) After Health Canada Authorization News - Yahoo Finance
Is Iovance Biotherapeutics Inc. a turnaround storyJuly 2025 Pullbacks & Fast Gaining Stock Strategy Reports - beatles.ru
Iovance Biotherapeutics Soars as Health Canada Approves Amtagvi T Cell Therapy - StocksToTrade
Iovance Biotherapeutics Leaps Forward with Health Canada Approval - timothysykes.com
683 Capital Management LLC Boosts Stock Holdings in Iovance Biotherapeutics, Inc. $IOVA - MarketBeat
Iovance Biotherapeutics Secures Canadian Approval for Groundbreaking Therapy - StocksToTrade
Iovance Biotherapeutics Surges After Amtagvi Approval in Canada - timothysykes.com
Is Iovance Biotherapeutics Inc. benefiting from interest rate changes2025 Biggest Moves & Growth Focused Entry Point Reports - خودرو بانک
Using Bollinger Bands to evaluate Iovance Biotherapeutics Inc.Trade Ideas & Long-Term Investment Growth Plans - Newser
What institutional flow reveals about Iovance Biotherapeutics Inc.IPO Watch & Low Risk Investment Opportunities - Newser
Using economic indicators to assess Iovance Biotherapeutics Inc. potentialWeekly Trade Review & Real-Time Volume Analysis - Newser
Iovance Biotherapeutics at Wells Fargo Conference: Strategic Moves and Challenges - Investing.com Canada
Is this a good reentry point in Iovance Biotherapeutics Inc.Weekly Investment Report & Low Drawdown Momentum Ideas - Newser
Should I add Iovance Biotherapeutics Inc. stock to my portfolio2025 Technical Patterns & Weekly Stock Performance Updates - خودرو بانک
How to use a screener to detect Iovance Biotherapeutics Inc. breakoutsTrade Analysis Summary & Safe Entry Trade Reports - Newser
Multi factor analysis applied to Iovance Biotherapeutics Inc.Weekly Investment Summary & AI Powered Trade Plan Recommendations - Newser
How to read the order book for Iovance Biotherapeutics Inc.July 2025 Spike Watch & Real-Time Stock Entry Alerts - Newser
Chart based analysis of Iovance Biotherapeutics Inc. trendsNew Guidance & Breakout Confirmation Trade Signals - Newser
Tools to monitor Iovance Biotherapeutics Inc. recovery probabilityEarnings Beat & AI Enhanced Trading Alerts - Newser
Iovance Biotherapeutics, Inc. $IOVA Shares Acquired by Long Focus Capital Management LLC - MarketBeat
Is Iovance Biotherapeutics Inc. forming a bottoming baseJuly 2025 Spike Watch & Risk Controlled Daily Trade Plans - Newser
Does Iovance Biotherapeutics Inc. qualify in momentum factor screeningAnalyst Upgrade & Safe Investment Capital Preservation Plans - Newser
Key resistance and support levels for Iovance Biotherapeutics Inc.Trade Analysis Report & Weekly Momentum Picks - Newser
Reversal indicators forming on Iovance Biotherapeutics Inc. stockTrade Risk Summary & Consistent Return Strategy Ideas - Newser
Artisan Small Cap Fund Exited Its Stake in Iovance Biotherapeutics (IOVA) Due to Operational Challenges - MSN
Short Term Charts Align With Long Term Uptrend in Iovance Biotherapeutics Inc.July 2025 Recap & Free Weekly Watchlist of Top Performers - beatles.ru
Iovance Biotherapeutics Inc (IOVA) 財務データ
収益
当期純利益
現金流量
EPS
Iovance Biotherapeutics Inc (IOVA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Puri Raj K. | Chief Regulatory Officer |
Sep 02 '25 |
Option Exercise |
0.00 |
5,470 |
0 |
215,324 |
| GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer |
Sep 02 '25 |
Option Exercise |
0.00 |
12,697 |
0 |
111,857 |
| BILINSKY IGOR | Chief Operating Officer |
Sep 02 '25 |
Option Exercise |
0.00 |
12,306 |
0 |
105,939 |
| Kirby Daniel Gordon | Chief Commercial Officer |
Jun 05 '25 |
Buy |
1.84 |
30,000 |
55,200 |
30,000 |
| Puri Raj K. | Chief Regulatory Officer |
Jun 02 '25 |
Option Exercise |
0.00 |
5,469 |
0 |
212,321 |
| Vogt Frederick G | Interim CEO & General Counsel |
Jun 02 '25 |
Option Exercise |
0.00 |
52,085 |
0 |
426,731 |
| GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer |
Jun 02 '25 |
Option Exercise |
0.00 |
12,695 |
0 |
105,608 |
| BILINSKY IGOR | Chief Operating Officer |
Jun 02 '25 |
Option Exercise |
0.00 |
12,305 |
0 |
99,883 |
| Bellemin Jean-Marc | Chief Financial Officer |
Jun 02 '25 |
Option Exercise |
0.00 |
8,789 |
0 |
64,993 |
| Puri Raj K. | Chief Regulatory Officer |
May 23 '25 |
Buy |
1.74 |
5,600 |
9,743 |
206,852 |
0.03%
0.09%
大文字化:
|
ボリューム (24 時間):